RTW Investments’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

RTW Investments’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-86	Closed	-$648K	–	33
2017 Q1	$648K	Buy	86 +1	+1%	+$6.92K	0.17%	25
2016 Q4	$476K	Buy	85 +38	+81%	+$194K	0.18%	26
2016 Q3	$389K	Hold	47	–	–	0.12%	31
2016 Q2	$455K	Hold	47	–	–	0.16%	33
2016 Q1	$764K	Buy	47 +22	+88%	+$498K	0.28%	28
2015 Q4	$563K	Hold	25	–	–	0.18%	26
2015 Q3	$382K	Hold	25	–	–	0.12%	36
2015 Q2	$949K	Buy	+25	New	+$985K	0.28%	28

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

RTW Investments's TMBR Position: Q2 2017 in Review

RTW Investments sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q2 2017, closing a stake of 86 shares — an estimated $648K sold.

RTW Investments first reported a position in TMBR in Q2 2015 and held it in 8 quarters. The position peaked at $949K in Q2 2015. 17 funds tracked by Wall St. Rank hold TMBR as of Q2 2017.

RTW Investments reported no remaining Timber Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
RTW Investments sold 86 Timber Pharmaceuticals, Inc. shares in Q2 2017, an estimated $648K.
RTW Investments first reported a position in Timber Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
RTW Investments's Timber Pharmaceuticals, Inc. position peaked at $949K in Q2 2015.
17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q2 2017.

Based on RTW Investments's 13F filing for Q2 2017, filed 14 Aug 2017.